Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia

Sokkosal Chea, Yi Bing Cheng, Kulkanya Chokephaibulkit, Tawee Chotpitayasunondh, H. Rogier van Doorn, Zen Hafy, Surinda Kawichai, Ching-Chuan Liu, Nguyen T.ran Nam, Mong H.ow Ooi, Marcel Wolbers, Mei Zeng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The South East Asia Infectious Disease Clinical Research Network convened subject matter experts at a workshop to make consensus recommendations for study design of a clinical trial for use of intravenous immunoglobulin (IVIg) in severe hand, foot and mouth disease (HFMD). HFMD is a highly contagious emerging infection among children in the region, a small proportion of whom develop neurologic and cardiopulmonary complications with high case-fatality rates. The use of IVIg for treatment of severe disease is widespread and a part of local, national, and international guidelines, but no clinical evidence warrants the use of this drug, which is expensive and has potentially serious side effects. During a 2-day workshop in March 2014, a group of HFMD experts reviewed the current evidence related to use of IVIg in HFMD and discussed potential study design, feasibility, inclusion and exclusion criteria, sample size, primary and secondary endpoints, and subsidiary studies for a randomized, placebo-controlled trial.

Original languageEnglish
JournalEmerging infectious diseases
Volume21
Issue number1
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Hand, Foot and Mouth Disease
Southeastern Asia
Intravenous Immunoglobulins
Education
Far East
Feasibility Studies
Sample Size
Nervous System
Communicable Diseases
Randomized Controlled Trials
Placebos
Clinical Trials
Guidelines
Mortality
Infection
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Chea, S., Cheng, Y. B., Chokephaibulkit, K., Chotpitayasunondh, T., Rogier van Doorn, H., Hafy, Z., ... Zeng, M. (2015). Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerging infectious diseases, 21(1). https://doi.org/10.3201/eid2101.140992
Chea, Sokkosal ; Cheng, Yi Bing ; Chokephaibulkit, Kulkanya ; Chotpitayasunondh, Tawee ; Rogier van Doorn, H. ; Hafy, Zen ; Kawichai, Surinda ; Liu, Ching-Chuan ; Nam, Nguyen T.ran ; Ooi, Mong H.ow ; Wolbers, Marcel ; Zeng, Mei. / Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. In: Emerging infectious diseases. 2015 ; Vol. 21, No. 1.
@article{b1c3f8ee8a8e4083a08da90295582c62,
title = "Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia",
abstract = "The South East Asia Infectious Disease Clinical Research Network convened subject matter experts at a workshop to make consensus recommendations for study design of a clinical trial for use of intravenous immunoglobulin (IVIg) in severe hand, foot and mouth disease (HFMD). HFMD is a highly contagious emerging infection among children in the region, a small proportion of whom develop neurologic and cardiopulmonary complications with high case-fatality rates. The use of IVIg for treatment of severe disease is widespread and a part of local, national, and international guidelines, but no clinical evidence warrants the use of this drug, which is expensive and has potentially serious side effects. During a 2-day workshop in March 2014, a group of HFMD experts reviewed the current evidence related to use of IVIg in HFMD and discussed potential study design, feasibility, inclusion and exclusion criteria, sample size, primary and secondary endpoints, and subsidiary studies for a randomized, placebo-controlled trial.",
author = "Sokkosal Chea and Cheng, {Yi Bing} and Kulkanya Chokephaibulkit and Tawee Chotpitayasunondh and {Rogier van Doorn}, H. and Zen Hafy and Surinda Kawichai and Ching-Chuan Liu and Nam, {Nguyen T.ran} and Ooi, {Mong H.ow} and Marcel Wolbers and Mei Zeng",
year = "2015",
month = "1",
day = "1",
doi = "10.3201/eid2101.140992",
language = "English",
volume = "21",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "1",

}

Chea, S, Cheng, YB, Chokephaibulkit, K, Chotpitayasunondh, T, Rogier van Doorn, H, Hafy, Z, Kawichai, S, Liu, C-C, Nam, NTR, Ooi, MHO, Wolbers, M & Zeng, M 2015, 'Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia', Emerging infectious diseases, vol. 21, no. 1. https://doi.org/10.3201/eid2101.140992

Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. / Chea, Sokkosal; Cheng, Yi Bing; Chokephaibulkit, Kulkanya; Chotpitayasunondh, Tawee; Rogier van Doorn, H.; Hafy, Zen; Kawichai, Surinda; Liu, Ching-Chuan; Nam, Nguyen T.ran; Ooi, Mong H.ow; Wolbers, Marcel; Zeng, Mei.

In: Emerging infectious diseases, Vol. 21, No. 1, 01.01.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia

AU - Chea, Sokkosal

AU - Cheng, Yi Bing

AU - Chokephaibulkit, Kulkanya

AU - Chotpitayasunondh, Tawee

AU - Rogier van Doorn, H.

AU - Hafy, Zen

AU - Kawichai, Surinda

AU - Liu, Ching-Chuan

AU - Nam, Nguyen T.ran

AU - Ooi, Mong H.ow

AU - Wolbers, Marcel

AU - Zeng, Mei

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The South East Asia Infectious Disease Clinical Research Network convened subject matter experts at a workshop to make consensus recommendations for study design of a clinical trial for use of intravenous immunoglobulin (IVIg) in severe hand, foot and mouth disease (HFMD). HFMD is a highly contagious emerging infection among children in the region, a small proportion of whom develop neurologic and cardiopulmonary complications with high case-fatality rates. The use of IVIg for treatment of severe disease is widespread and a part of local, national, and international guidelines, but no clinical evidence warrants the use of this drug, which is expensive and has potentially serious side effects. During a 2-day workshop in March 2014, a group of HFMD experts reviewed the current evidence related to use of IVIg in HFMD and discussed potential study design, feasibility, inclusion and exclusion criteria, sample size, primary and secondary endpoints, and subsidiary studies for a randomized, placebo-controlled trial.

AB - The South East Asia Infectious Disease Clinical Research Network convened subject matter experts at a workshop to make consensus recommendations for study design of a clinical trial for use of intravenous immunoglobulin (IVIg) in severe hand, foot and mouth disease (HFMD). HFMD is a highly contagious emerging infection among children in the region, a small proportion of whom develop neurologic and cardiopulmonary complications with high case-fatality rates. The use of IVIg for treatment of severe disease is widespread and a part of local, national, and international guidelines, but no clinical evidence warrants the use of this drug, which is expensive and has potentially serious side effects. During a 2-day workshop in March 2014, a group of HFMD experts reviewed the current evidence related to use of IVIg in HFMD and discussed potential study design, feasibility, inclusion and exclusion criteria, sample size, primary and secondary endpoints, and subsidiary studies for a randomized, placebo-controlled trial.

UR - http://www.scopus.com/inward/record.url?scp=85003411170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003411170&partnerID=8YFLogxK

U2 - 10.3201/eid2101.140992

DO - 10.3201/eid2101.140992

M3 - Article

C2 - 25531166

AN - SCOPUS:85003411170

VL - 21

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 1

ER -

Chea S, Cheng YB, Chokephaibulkit K, Chotpitayasunondh T, Rogier van Doorn H, Hafy Z et al. Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerging infectious diseases. 2015 Jan 1;21(1). https://doi.org/10.3201/eid2101.140992